Observational Study
Copyright ©The Author(s) 2016.
World J Obstet Gynecol. Feb 10, 2016; 5(1): 127-133
Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.127
Table 3 Variation of use of menopausal hormone treatment and risk of serious outcomes : Age of patient and duration of use
Relative risk estimate (95%Cl)
Coronaryartery diseaseStrokePeripheral artery diseaseBreast cancer
Age of patient when treatment started (yr)
20-390.48 (0.07, 3.35)0.68 (0.09, 5.35)1.57 (0.19, 12.79)0.83 (0.11, 6.57)
P = 0.47P = 0.72P = 0.67P = 0.87
40-491.14 (0.55, 2.37)0.98 (0.41, 2.37)2.25 (0.85, 5.96)0.66 (0.22, 1.97)
P = 0.72P = 0.97P = 0.10P = 0.45
50-590.83 (0.37, 1.87)1.18 (0.51, 2.75)1.63 (0.55, 4.79)0.87 (0.32, 2.38)
P = 0.65P = 0.69P = 0.37P = 0.78
60-797.7 (2.85, 20.76)2.19 (0.59, 8.11)5.01 (1.27, 19.80)1.67 (0.36, 7.77)
P < 0.001P = 0.24P = 0.02P = 0.52
Age of patient when treatment stopped (yr)
20-391.36 (0.38, 4.88)1.22 (0.27, 5.56)2.79 (0.57, 13.53)1.48 (0.32, 6.85)
P = 0.64P = 0.80P = 0.20P = 0.61
40-490.48 (0.18, 1.27)0.54 (0.18, 1.59)0.92 (0.25, 3.37)0.32 (0.97, 1.41)
P = 0.50P = 0.26P = 0.90P = 0.13
50-591.3 (0.61, 2.80)1.24 (0.51, 3.00)2.83 (1.06, 7.60)1.75 (0.74, 4.16)
P = 0.50P = 0.64P = 0.04P = 0.20
60-794.98 (2.19, 11.55)2.99 (1.11, 8.08)4.18 (1.24, 14.14)NC
P < 0.001P = 0.03P = 0.02
Duration of use (yr)
< 11.1 (0.24, 5.04)NC3.59 (0.72, 17.75)1.91 (0.40, 8.98)
P = 0.90P = 0.12P = 0.41
1-50.76 (0.31, 1.87)1.28 (0.53, 3.11)1.18 (0.32, 4.34)0.85 (0.28, 2.57)
P = 0.55P = 0.59P = 0.81P = 0.77
6-102.12 (0.90, 5.03)0.3 (0.04, 2.32)1.43 (0.31, 6.74)0.37 (0.40, 2.85)
P = 0.09P = 0.25P = 0.65P = 0.34
11-150.75 (0.26, 2.20)1.69 (0.65, 4.38)3.14 (1.04, 9.50)0.95 (0.27, 3.35)
P = 0.60P = 0.28P = 0.04P = 0.94
16-202.75 (0.93, 8.11)1.29 (0.28, 5.92)NC0.74 (0.09, 5.84)
P = 0.07P = 0.74P = 0.78
21-252.89 (0.73, 11.41)2.44 (0.50, 11.92)5.57 (1.07, 28.92)1.33 (0.16, 10.96)
P = 0.13P = 0.27P = 0.04P = 0.79
26+1.28 (0.15, 10.97)1.83 (0.21, 15.80)10.03 (1.75, 57.58)NC
P = 0.82P = 0.58P = 0.01